Forum Financial Management LP Invests $300,000 in Church & Dwight Co., Inc. (NYSE:CHD)

Forum Financial Management LP acquired a new position in Church & Dwight Co., Inc. (NYSE:CHD - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 2,863 shares of the company's stock, valued at approximately $300,000.

Several other large investors also recently bought and sold shares of the business. Pacific Point Advisors LLC bought a new stake in Church & Dwight in the 4th quarter worth about $1,286,000. Sunbelt Securities Inc. increased its holdings in Church & Dwight by 10.0% in the 4th quarter. Sunbelt Securities Inc. now owns 5,333 shares of the company's stock worth $558,000 after buying an additional 485 shares in the last quarter. GTS Securities LLC increased its holdings in Church & Dwight by 1,361.8% in the 4th quarter. GTS Securities LLC now owns 3,406 shares of the company's stock worth $357,000 after buying an additional 3,173 shares in the last quarter. Vise Technologies Inc. bought a new stake in Church & Dwight in the 4th quarter worth about $433,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Church & Dwight by 5.5% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,404,961 shares of the company's stock valued at $251,823,000 after purchasing an additional 124,560 shares during the period. 86.60% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the company. Wall Street Zen downgraded Church & Dwight from a "hold" rating to a "sell" rating in a research note on Tuesday, May 20th. Truist Financial boosted their price target on Church & Dwight from $110.00 to $115.00 and gave the company a "buy" rating in a research note on Monday, February 3rd. JPMorgan Chase & Co. cut their price target on Church & Dwight from $106.00 to $98.00 and set an "underweight" rating for the company in a research note on Friday, April 11th. UBS Group cut their price target on Church & Dwight from $110.00 to $102.00 and set a "neutral" rating for the company in a research note on Friday, May 2nd. Finally, Wells Fargo & Company boosted their price target on Church & Dwight from $115.00 to $120.00 and gave the company an "overweight" rating in a research note on Wednesday, April 2nd. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $109.13.

Insider Buying and Selling

In related news, EVP Carlen Hooker sold 3,000 shares of the business's stock in a transaction that occurred on Thursday, May 29th. The stock was sold at an average price of $98.05, for a total value of $294,150.00. Following the transaction, the executive vice president now directly owns 262 shares of the company's stock, valued at approximately $25,689.10. The trade was a 91.97% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Maynadier Patrick D. De sold 54,510 shares of the company's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $115.98, for a total value of $6,322,069.80. Following the sale, the executive vice president now directly owns 10,497 shares in the company, valued at $1,217,442.06. This trade represents a 83.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 83,230 shares of company stock valued at $9,197,884. Corporate insiders own 2.00% of the company's stock.

Church & Dwight Stock Performance

Shares of NYSE:CHD traded up $0.31 during mid-day trading on Friday, reaching $98.45. 4,911,224 shares of the company traded hands, compared to its average volume of 1,688,871. The company's 50 day moving average price is $100.08 and its 200-day moving average price is $104.76. The firm has a market cap of $24.25 billion, a PE ratio of 41.54, a PEG ratio of 3.32 and a beta of 0.55. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.70 and a quick ratio of 1.24. Church & Dwight Co., Inc. has a 52 week low of $90.99 and a 52 week high of $116.46.

Church & Dwight (NYSE:CHD - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The company reported $0.91 EPS for the quarter, topping analysts' consensus estimates of $0.89 by $0.02. Church & Dwight had a return on equity of 20.03% and a net margin of 9.58%. The company had revenue of $1.47 billion for the quarter, compared to analysts' expectations of $1.52 billion. During the same period in the previous year, the firm earned $0.96 EPS. The firm's revenue was down 2.4% compared to the same quarter last year. On average, equities analysts expect that Church & Dwight Co., Inc. will post 3.7 EPS for the current fiscal year.

Church & Dwight Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 2nd. Investors of record on Thursday, May 15th will be issued a $0.295 dividend. The ex-dividend date is Thursday, May 15th. This represents a $1.18 dividend on an annualized basis and a yield of 1.20%. Church & Dwight's dividend payout ratio is presently 50.64%.

Church & Dwight Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.